HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Babesia bovis dihydroorotate dehydrogenase (BboDHODH) is a novel molecular target of drug for bovine babesiosis.

Abstract
The emergence of drug resistance and adverse side effects of current bovine babesiosis treatment suggest that the search of new drug targets and development of safer and effective compounds are required. This study focuses on dihydroorotate dehydrogenase (DHODH), the fourth enzyme of pyrimidine biosynthesis pathway as a potential drug target for bovine babesiosis. Recombinant Babesia bovis DHODH protein (rBboDHODH) was produced in Escherichia coli and used for characterization and measurement of enzymatic activity. Furthermore, the effects of DHODH inhibitors were evaluated in vitro. The recombinant B. bovis DHODH histidine fusion protein (rBboDHODH) had 42.4-kDa molecular weight and exhibited a specific activity of 475.7 ± 245 Unit/mg, a Km = 276.2 µM for L-dihydroorotate and a Km= 94.41 µM for decylubiquinone. A 44-kDa band of native BboDHODH was detected by Western blot analysis and found in parasites mitochondria using a confocal microscope. Among DHODH inhibitors, atovaquone (ATV) and leflunomide (LFN) significantly inhibited the activity of rBboDHODH as well as the growth of B. bovis in vitro. The half maximal inhibitory concentration (IC50) of ATV and LFN was 2.38 ± 0.53 nM and 52.41 ± 11.47 µM, respectively. These results suggest that BboDHODH might be a novel target for development of new drug for treatment of B. bovis infection.
AuthorsKetsarin Kamyingkird, Shinuo Cao, Tatsunori Masatani, Paul Franck Adjou Moumouni, Patrick Vudriko, Ahmed Abd El Moniem Mousa, Mohamad Alaa Terkawi, Yoshifumi Nishikawa, Ikuo Igarashi, Xuenan Xuan
JournalThe Journal of veterinary medical science (J Vet Med Sci) Vol. 76 Issue 3 Pg. 323-30 (Mar 2014) ISSN: 1347-7439 [Electronic] Japan
PMID24189582 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Dihydroorotate Dehydrogenase
  • Enzyme Inhibitors
  • Recombinant Fusion Proteins
  • Oxidoreductases Acting on CH-CH Group Donors
Topics
  • Amino Acid Sequence
  • Animals
  • Babesia bovis (enzymology)
  • Babesiosis (drug therapy, metabolism)
  • Blotting, Western
  • Cattle
  • Cattle Diseases (drug therapy, parasitology)
  • Cloning, Molecular
  • Computational Biology
  • DNA Primers (genetics)
  • Dihydroorotate Dehydrogenase
  • Drug Delivery Systems
  • Drug Discovery
  • Enzyme Inhibitors (metabolism)
  • Escherichia coli
  • Microscopy, Confocal
  • Molecular Sequence Data
  • Oxidoreductases Acting on CH-CH Group Donors (genetics, metabolism)
  • Phylogeny
  • Recombinant Fusion Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: